The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation
Official Title: Nexium Capsules Specific Clinical Experience Investigation Concerning Helicobacter Pylori Eradication
Study ID: NCT01435525
Brief Summary: The purpose of this study is to confirm the safety profile / factors which impact safety and efficacy in patients given triple therapy for Helicobacter pylori eradication with Nexium + amoxicillin (AMPC) + clarithromycin (CAM), or Nexium + AMPC + metronidazole (MNZ) in usual post-marketing use.
Detailed Description: Nexium capsules Specific Clinical Experience Investigation concerning Helicobacter pylori eradication
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Research Site, Aichi, , Japan
Research Site, Akita, , Japan
Research Site, Chiba, , Japan
Research Site, Ehime, , Japan
Research Site, Fukuoka, , Japan
Research Site, Fukushima, , Japan
Research Site, Gifu, , Japan
Research Site, Gunma, , Japan
Research Site, Hiroshima, , Japan
Research Site, Hokkaido, , Japan
Research Site, Hyogo, , Japan
Research Site, Ibaraki, , Japan
Research Site, Iwate, , Japan
Research Site, Kagawa, , Japan
Research Site, Kanagawa, , Japan
Research Site, Kochi, , Japan
Research Site, Kumamoto, , Japan
Research Site, Kyoto, , Japan
Research Site, Mie, , Japan
Research Site, Miyagi, , Japan
Research Site, Nagano, , Japan
Research Site, Nagasaki, , Japan
Research Site, Niigata, , Japan
Research Site, Oita, , Japan
Research Site, Okayama, , Japan
Research Site, Okinawa, , Japan
Research Site, Osaka, , Japan
Research Site, Saitama, , Japan
Research Site, Shiga, , Japan
Research Site, Shimane, , Japan
Research Site, Shizuoka, , Japan
Research Site, Tokyo, , Japan
Research Site, Toyama, , Japan
Research Site, Wakayama, , Japan
Research Site, Yamagata, , Japan
Research Site, Yamanashi, , Japan
Name: Shigeru Yoshida, MD
Affiliation: AstraZeneca K.K.
Role: STUDY_DIRECTOR